Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m

High Altitude Medicine and Biology

Volumn 10, Issue 1, 2009, Pages 25-32

  Bloch, Konrad E ^a   Turk, Alexander J ^a   Maggiorini, Marco ^a   Hess, Thomas ^b   Merz, Tobias ^c   Bosch, Martina M ^a   Barthelmes, Daniel ^a   Hefti, Urs ^d   Pichler, Jacqueline ^d   Senn, Oliver ^a   Schoch, Otto D ^e  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CANTONAL HOSPITAL WINTERTHUR   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

^d CANTONAL HOSPITAL AARAU   (Switzerland)

^e CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Altitude; Altitude related illness; Exercise; Hypoxia; Mountaineering; Randomized trial

Indexed keywords

ADULT; ALTITUDE DISEASE; ARTICLE; CHINA; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOUNTAINEERING; NORMAL HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM; WEATHER;

ACCLIMATIZATION; ADULT; ALTITUDE SICKNESS; FEMALE; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; MOUNTAINEERING; OXYGEN CONSUMPTION; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 62549156661     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2008.1043     Document Type: Article

References (20)

1. American Thoracic Society/ACCP Statement on cardiopulmonary exercise testing. (2003). Am. J. Respir. Crit. Care Med. 167:211-277.
2. Basnyat B., and Murdoch D.R. (2003). High-altitude illness. Lancet. 361:1967-1974.
3. Beidleman B.A., Muza S.R., Fulco C.S., Cymerman A., Ditzler D., Stulz D., Staab J.E., Skrinar G.S., Lewis S.F., and Sawka M.N. (2004). Intermittent altitude exposures reduce acute mountain sickness at 4300 m. Clin. Sci. (Lond.) 106:321-328.
4. Burtscher M., Flatz M., and Faulhaber M. (2004). Prediction of susceptibility to acute mountain sickness by SaO2 values during short-term exposure to hypoxia. High Alt. Med. Biol. 5:335-340.
5. Erba P., Anastasi S., Senn O., Maggiorini M., and Bloch K.E. (2004). Acute mountain sickness is related to nocturnal hypoxemia but not to hypoventilation. Eur. Respir. J. 24:303-308.
6. Gertsch J.H., Basnyat B., Johnson E.W., Onopa J., and Holck P.S. (2004). Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). BMJ. 328:797.
7. Hackett P.H., Rennie D., and Levine H.D. (1976). The incidence, importance, and prophylaxis of acute mountain sickness. Lancet. 2:1149-1155.
8. Hackett P.H., and Roach R.C. (2001). High-altitude illness. N. Engl. J. Med. 345:107-114.
9. Hackett P.H., Roach R.C., Wood R.A., Foutch R.G., Meehan R.T., Rennie D., and Mills W.J., Jr. (1988). Dexamethasone for prevention and treatment of acute mountain sickness. Aviat. Space Environ. Med. 59:950-954.
10. Kirkwood B.R., and Sterne J.A.C. Essential Medical Statistics, 2nd ed. (2003). Blackwell Publishers, Oxford, UK.
11. Maggiorini M., Buhler B., Walter M., and Oelz O. (1990). Prevalence of acute mountain sickness in the Swiss Alps. BMJ. 301:853-855.
12. Maggiorini M., Muller A., Hofstetter D., Bartsch P., and Oelz O. (1998). Assessment of acute mountain sickness by different score protocols in the Swiss Alps. Aviat. Space Environ. Med. 69:1186-1192.
13. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., Crapo R., Enright P., van der Grinten C.P., Gustafsson P., Jensen R., Johnson D.C., MacIntyre N., McKay R., Navajas D., Pedersen O.F., Pellegrino R., Viegi G., and Wanger J. (2005). Standardisation of spirometry. Eur. Respir. J. 26:319-338.
14. O'Connor T., Dubowitz G., and Bickler P.E. (2004). Pulse oximetry in the diagnosis of acute mountain sickness. High Alt. Med. Biol. 5:341-348.
15. Pesce C., Leal C., Pinto H., Gonzalez G., Maggiorini M., Schneider M., and Bartsch P. (2005). Determinants of acute mountain sickness and success on Mount Aconcagua (6962 m). High Alt. Med. Biol. 6:158-166.
16. Purkayastha S.S., Ray U.S., Arora B.S., Chhabra P.C., Thakur L., Bandopadhyay P., and Selvamurthy W. (1995). Acclimatization at high altitude in gradual and acute induction. J. Appl. Physiol. 79:487-492.
17. Roach, R.C., Bartsch, P., Hackett, P.H., Oelz, O., and the Lake Louise AMS Scoring Consensus Committee. (1993). The Lake Louise acute montain sickness scoring system. In: Hypoxia and Molecular Medicine: Proceedings of the 8th International Hypoxia Symposium. J. R. Sutton, G. Coates, and C.S. Huston, eds. Queen City Printers, Burlington, VT; pp. 272-274.
18. Roach R.C., Maes D., Sandoval D., Robergs R.A., Icenogle M., Hinghofer-Szalkay H., Lium D., and Loeppky J.A. (2000). Exercise exacerbates acute mountain sickness at simulated high altitude. J. Appl. Physiol. 88:581-585.
19. Sampson J.B., Cymerman A., Burse R.L., Maher J.T., and Rock P.B. (1983). Procedures for the measurement of acute mountain sickness. Aviat. Space Environ. Med. 54:1063-1073.
20. Schneider M., Bernasch D., Weymann J., Holle R., and Bartsch P. (2002). Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med. Sci. Sports Exerc. 34:1886-1891.